Alpha Cognition to present ZUNVEYL® data at ASCP and NEI meetings

Alpha Cognition Inc. will present new clinical and real-world data on its Alzheimer's disease treatment ZUNVEYL® at the American Society of Consultant Pharmacists (ASCP) Annual Meeting and the Neuroscience Education Institute (NEI) Fall Congress. The presentations will cover various aspects of Alzheimer's care and ZUNVEYL use.